Skip to main content

This site is intended for US healthcare professionals only.

TAKE A GUIDED TOUR TO DISCOVER WHAT THIS NON-HORMONAL CONTRACEPTIVE OPTION HAS TO OFFER.    START NOW!
Toggle X
phexxi-non-hormonal-birth-control-rep-icon

Contact an Evofem Regional Business Manager

All fields required.

Contact preference:
Best time to reach:
Are you:
Form Submitted Thank You

pHANTASTIC!
QUICK AND EASY TO USE1

  • After application, 1 dose of Phexxi:
    • is effective immediately2
    • will last up to 1 hour2
    • provides protection for 1 act of vaginal intercourse2
phexxi-non-hormonal-birth-control-dosing-productphexxi-non-hormonal-birth-control-dosing-directions
INSTRUCTIONS FOR YOUR PATIENTS2
  • Intravaginally administer the contents of 1 pre-filled, single-dose applicator of Phexxi before each episode of vaginal intercourse
  • Administer an additional dose if intercourse does not occur within 1 hour of administration
  • An additional dose of Phexxi needs to be used if vaginal intercourse occurs more than 1 time within 1 hour, the same way a new condom would be used for each episode of vaginal intercourse

HAVE QUESTIONS? LEARN MORE HERE

IMPORTANT SAFETY INFORMATION

WARNINGS AND PRECAUTIONS

Few cases (0.36%) of adverse reactions of cystitis, pyelonephritis and other upper urinary tract infection (UTI) have been reported in Phexxi clinical studies. Of these, one case of pyelonephritis was considered serious and required hospitalization. Avoid use of Phexxi in females of reproductive potential with history of recurrent urinary tract infection or urinary tract abnormalities.

ADVERSE REACTIONS

Most common adverse reactions were vulvovaginal burning sensation, vulvovaginal pruritus, vulvovaginal mycotic infection, urinary tract infection, vulvovaginal discomfort, bacterial vaginosis, vaginal discharge, genital discomfort, dysuria, and vulvovaginal pain.

Patients should be counseled on the following:

  • To contact and consult with their healthcare provider for severe or prolonged genital irritation or experiencing urinary tract symptoms.
  • To discontinue Phexxi if they develop a local hypersensitivity reaction.
  • That Phexxi does not protect against HIV infection or other sexually transmitted infections.

To report SUSPECTED ADVERSE REACTIONS, contact Evofem at toll-free phone 1-833-EVFMBIO or you may contact FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

INDICATIONS AND USAGE

Phexxi is indicated for the prevention of pregnancy in females of reproductive potential for use as an on-demand method of contraception.

LIMITATIONS OF USE

Phexxi is not effective for the prevention of pregnancy when administered after intercourse.

Please see full Prescribing Information for Phexxi.

REFERENCES:

  1. Data on file. Evofem Biosciences, Inc.
  2. Phexxi [Prescribing Information]. Evofem Biosciences, Inc.: San Diego, CA; May 2020.
Expand ISI

IMPORTANT SAFETY INFORMATION

WARNINGS AND PRECAUTIONS

Few cases (0.36%) of adverse reactions of cystitis, pyelonephritis and other upper urinary tract infection (UTI) have been reported in Phexxi clinical studies. Of these, one case of pyelonephritis was considered serious and required hospitalization. Avoid use of Phexxi in females of reproductive potential with history of recurrent urinary tract infection or urinary tract abnormalities.